These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18573861)

  • 1. Identification of enzymes involved in the metabolism of 17alpha-hydroxyprogesterone caproate: an effective agent for prevention of preterm birth.
    Sharma S; Ou J; Strom S; Mattison D; Caritis S; Venkataramanan R
    Drug Metab Dispos; 2008 Sep; 36(9):1896-902. PubMed ID: 18573861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes.
    Sharma S; Ellis EC; Dorko K; Zhang S; Mattison DR; Caritis SN; Venkataramanan R; Strom SC
    Drug Metab Dispos; 2010 May; 38(5):723-7. PubMed ID: 20097724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth - A Systematic Review and Meta-analysis Taking into Account the PROLONG Trial.
    Kuon RJ; Berger R; Rath W
    Geburtshilfe Frauenheilkd; 2021 Jan; 81(1):61-69. PubMed ID: 33487666
    [No Abstract]   [Full Text] [Related]  

  • 4. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.
    Bustos ML; Caritis SN; Jablonski KA; Reddy UM; Sorokin Y; Manuck T; Varner MW; Wapner RJ; Iams JD; Carpenter MW; Peaceman AM; Mercer BM; Sciscione A; Rouse DJ; Ramin SM;
    Am J Obstet Gynecol; 2017 Sep; 217(3):369.e1-369.e9. PubMed ID: 28522317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.
    Feghali M; Venkataramanan R; Caritis S
    Semin Perinatol; 2014 Dec; 38(8):516-22. PubMed ID: 25256193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS).
    Zhang S; Mada SR; Sharma S; Torch M; Mattison D; Caritis S; Venkataramanan R
    J Pharm Biomed Anal; 2008 Dec; 48(4):1174-80. PubMed ID: 18947956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation.
    Sharma S; Caritis S; Hankins G; Miodovnik M; Hebert MF; Mattison D; Venkataramanan R
    Br J Clin Pharmacol; 2016 Oct; 82(4):1084-93. PubMed ID: 27133963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth.
    Alizadeh F; Mahmoudinia M; Mirteimoori M; Pourali L; Niroumand S
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):167. PubMed ID: 35232423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does 17-α-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?
    Mulder EJ; Versteegh EM; Bloemenkamp KW; Lim AC; Mol BW; Bekedam DJ; Kwee A; Bruinse HW; Christiaens GC
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):329-34. PubMed ID: 23592400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of endogenous steroid hormones on 17-alpha-hydroxyprogesterone caproate metabolism.
    Cuppett CD; Zhao Y; Caritis S; Zhang S; Zhao W; Venkataramanan R
    Am J Obstet Gynecol; 2013 Jan; 208(1):86.e1-6. PubMed ID: 23063018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Possible Mechanism of Action of 17α-Hydroxyprogesterone Caproate: Enhanced IL-10 Production.
    Megli CJ; Hauspurg A; Venkataramanan R; Caritis SN
    Am J Perinatol; 2023 Oct; 40(14):1585-1589. PubMed ID: 34784615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate.
    Stetson B; Hibbard JU; Wilkins I; Leftwich H
    Obstet Gynecol; 2016 Nov; 128(5):983-988. PubMed ID: 27741201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.
    EPPPIC Group
    Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
    Saghafi N; Khadem N; Mohajeri T; Shakeri MT
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1342-5. PubMed ID: 21564406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth.
    Ward A; Greenberg V; Valcarcel B; Boelig RC; Al-Kouatly HB; Berghella V
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100124. PubMed ID: 33345870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
    Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck TA; Miller HS; Das AF; Saade GR; Nielsen P; Baker J; Yuzko OM; Reznichenko GI; Reznichenko NY; Pekarev O; Tatarova N; Gudeman J; Birch R; Jozwiakowski MJ; Duncan M; Williams L; Krop J
    Am J Perinatol; 2020 Jan; 37(2):127-136. PubMed ID: 31652479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention.
    Zhang S; Rascati KL
    Curr Med Res Opin; 2021 Sep; 37(9):1667-1675. PubMed ID: 34030550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of randomized controlled trials comparing 17-alpha-hydroxyprogesterone caproate versus placebo for the prevention of recurrent preterm birth.
    Fernandez-Macias R; Martinez-Portilla RJ; Cerrillos L; Figueras F; Palacio M
    Int J Gynaecol Obstet; 2019 Nov; 147(2):156-164. PubMed ID: 31402445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.